Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
Phase 1
- Conditions
- Peripheral Arterial DiseaseStenosisIntermittent Claudication
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- CardioVascular BioTherapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00424866
- Locations
- 🇺🇸
CVBT Info, Dallas, Texas, United States
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
Phase 1
Completed
- Conditions
- DiabetesVenous Stasis UlcersChronic Wounds
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- CardioVascular BioTherapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00425178
- Locations
- 🇺🇸
Warren General Hospital, Warren, Pennsylvania, United States
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease
Phase 2
- Conditions
- Coronary DiseaseCoronary Heart DiseaseMyocardial IschemiaCoronary Arteriosclerosis
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- CardioVascular BioTherapeutics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT00117936
News
No news found